Teduglutide - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510245099

Publication Date:

October 29, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Teduglutide听(brand names听Gattex听in the US and听Revestive听in Europe) is a 33-membered polypeptide听and听glucagon-like peptide-2听(GLP-2) analog that is used for the treatment of听short bowel syndrome.
The global market for Teduglutide was estimated to be worth US$ 751 million in 2023 and is forecast to a readjusted size of US$ 2122.1 million by 2030 with a CAGR of 16.0% during the forecast period 2024-2030
The Teduglutide market is primarily driven by the demand for innovative therapies to address short bowel syndrome (SBS) and improve the quality of life for affected patients. Teduglutide is a medication used to treat SBS, a condition characterized by impaired intestinal function due to surgical resection or congenital anomalies. The limited treatment options for SBS, coupled with advancements in gastrointestinal medicine and patient-centric care, contribute to market growth. Moreover, the demonstrated efficacy of Teduglutide in reducing dependence on parenteral nutrition and enhancing nutrient absorption further propels adoption. However, challenges include managing potential side effects and addressing patient access issues. Navigating regulatory approvals, optimizing treatment regimens, and ensuring long-term safety and efficacy are ongoing concerns. The market's success relies on continuous research in gastrointestinal disorders, collaborations between pharmaceutical manufacturers and gastroenterologists, and comprehensive patient education on the benefits and potential risks of Teduglutide treatment while addressing the evolving challenges associated with SBS management and treatment accessibility.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Teduglutide, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Teduglutide by region & country, by Type, and by Application.
The Teduglutide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Teduglutide.
麻豆原创 Segmentation
By Company
Takeda Pharmaceuticals
Segment by Type:
Gattex
Revestive
Segment by Application
Hospital
Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Teduglutide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Teduglutide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Teduglutide in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Teduglutide Product Introduction
1.2 Global Teduglutide 麻豆原创 Size Forecast
1.2.1 Global Teduglutide Sales Value (2019-2030)
1.2.2 Global Teduglutide Sales Volume (2019-2030)
1.2.3 Global Teduglutide Sales Price (2019-2030)
1.3 Teduglutide 麻豆原创 Trends & Drivers
1.3.1 Teduglutide Industry Trends
1.3.2 Teduglutide 麻豆原创 Drivers & Opportunity
1.3.3 Teduglutide 麻豆原创 Challenges
1.3.4 Teduglutide 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Teduglutide Players Revenue Ranking (2023)
2.2 Global Teduglutide Revenue by Company (2019-2024)
2.3 Global Teduglutide Players Sales Volume Ranking (2023)
2.4 Global Teduglutide Sales Volume by Company Players (2019-2024)
2.5 Global Teduglutide Average Price by Company (2019-2024)
2.6 Key Manufacturers Teduglutide Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Teduglutide Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Teduglutide
2.9 Teduglutide 麻豆原创 Competitive Analysis
2.9.1 Teduglutide 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Teduglutide Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Teduglutide as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Gattex
3.1.2 Revestive
3.2 Global Teduglutide Sales Value by Type
3.2.1 Global Teduglutide Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Teduglutide Sales Value, by Type (2019-2030)
3.2.3 Global Teduglutide Sales Value, by Type (%) (2019-2030)
3.3 Global Teduglutide Sales Volume by Type
3.3.1 Global Teduglutide Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Teduglutide Sales Volume, by Type (2019-2030)
3.3.3 Global Teduglutide Sales Volume, by Type (%) (2019-2030)
3.4 Global Teduglutide Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Other
4.2 Global Teduglutide Sales Value by Application
4.2.1 Global Teduglutide Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Teduglutide Sales Value, by Application (2019-2030)
4.2.3 Global Teduglutide Sales Value, by Application (%) (2019-2030)
4.3 Global Teduglutide Sales Volume by Application
4.3.1 Global Teduglutide Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Teduglutide Sales Volume, by Application (2019-2030)
4.3.3 Global Teduglutide Sales Volume, by Application (%) (2019-2030)
4.4 Global Teduglutide Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Teduglutide Sales Value by Region
5.1.1 Global Teduglutide Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Teduglutide Sales Value by Region (2019-2024)
5.1.3 Global Teduglutide Sales Value by Region (2025-2030)
5.1.4 Global Teduglutide Sales Value by Region (%), (2019-2030)
5.2 Global Teduglutide Sales Volume by Region
5.2.1 Global Teduglutide Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Teduglutide Sales Volume by Region (2019-2024)
5.2.3 Global Teduglutide Sales Volume by Region (2025-2030)
5.2.4 Global Teduglutide Sales Volume by Region (%), (2019-2030)
5.3 Global Teduglutide Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Teduglutide Sales Value, 2019-2030
5.4.2 North America Teduglutide Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Teduglutide Sales Value, 2019-2030
5.5.2 Europe Teduglutide Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Teduglutide Sales Value, 2019-2030
5.6.2 Asia Pacific Teduglutide Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Teduglutide Sales Value, 2019-2030
5.7.2 South America Teduglutide Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Teduglutide Sales Value, 2019-2030
5.8.2 Middle East & Africa Teduglutide Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Teduglutide Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Teduglutide Sales Value
6.2.1 Key Countries/Regions Teduglutide Sales Value, 2019-2030
6.2.2 Key Countries/Regions Teduglutide Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Teduglutide Sales Value, 2019-2030
6.3.2 United States Teduglutide Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Teduglutide Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Teduglutide Sales Value, 2019-2030
6.4.2 Europe Teduglutide Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Teduglutide Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Teduglutide Sales Value, 2019-2030
6.5.2 China Teduglutide Sales Value by Type (%), 2023 VS 2030
6.5.3 China Teduglutide Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Teduglutide Sales Value, 2019-2030
6.6.2 Japan Teduglutide Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Teduglutide Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Teduglutide Sales Value, 2019-2030
6.7.2 South Korea Teduglutide Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Teduglutide Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Teduglutide Sales Value, 2019-2030
6.8.2 Southeast Asia Teduglutide Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Teduglutide Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Teduglutide Sales Value, 2019-2030
6.9.2 India Teduglutide Sales Value by Type (%), 2023 VS 2030
6.9.3 India Teduglutide Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Takeda Pharmaceuticals
7.1.1 Takeda Pharmaceuticals Company Information
7.1.2 Takeda Pharmaceuticals Introduction and Business Overview
7.1.3 Takeda Pharmaceuticals Teduglutide Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Takeda Pharmaceuticals Teduglutide Product Offerings
7.1.5 Takeda Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Teduglutide Industrial Chain
8.2 Teduglutide Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Teduglutide Sales Model
8.5.2 Sales Channel
8.5.3 Teduglutide Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Takeda Pharmaceuticals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.